My bookmarksSign up free

Commission Decision of 17 December 2009 authorising a health claim on the effect of water-soluble tomato concentrate on platelet aggregation and granting the protection of proprietary data under Regulation (EC) No 1924/2006 of the European Parliament and of the Council (notified under document C(2009) 10113) (Text with EEA relevance)

Commission Decision of 17 December 2009 authorising a health claim on the effect of water-soluble tomato concentrate on platelet aggregation and granting the protection of proprietary data under Regulation (EC) No 1924/2006 of the European Parliament and of the Council (notified under document C(2009) 10113) (Text with EEA relevance)

Regulation (EC) No 1924/2006 · Decision · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The health claim set out in the Annex to this Decision shall be included in the Community list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.

Article 2

The scientific data and other information included in the studies identified in the Annex to this Decision shall be restricted for use for the benefit of the applicant for a period of 5 years from the date of authorisation under the conditions laid down in Article 21(1) of Regulation (EC) No 1924/2006.

Article 3

This Decision is addressed to Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, United Kingdom.

Supplementary provisions

ANNEXSupplementary provisions

ANNEX Applicant — Address Nutrient, substance, food or food category Claim Conditions of use of the claim Conditions and/or restrictions of use of the food and/or additional statement or warning Proprietary data restricted for use for the benefit of the applicant EFSA opinion reference Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, United Kingdom Water-Soluble Tomato Concentrate (WSTC) I and II Water-Soluble Tomato Concentrate (WSTC) I and II helps maintain normal platelet aggregation, which contributes to healthy blood flow Information to the consumer that the beneficial effect is obtained with a daily consumption of 3g WSTC I or 150 mg WSTC II in up to 250 ml of either fruit juices, flavoured drinks or yogurt drinks (unless heavily pasteurised)   1. O’Kennedy, N., Crosbie, L., van Lieshout M., Broom J.I., Webb, D.J., Duttaroy, A.K., 2003a. Persistence of the antiplatelet effect of a single dose of WSTC equivalent to 2 fresh tomatoes over a 24-hour timecourse . REC No 02/0269 2. O’Kennedy et al. 2003b. A 42-day randomised, controlled and double-blinded crossover study to evaluate effects of daily WSTC consumption on platelet function, coagulation and some baseline CVD risk markers . REC No 03/0177. 3. O’Kennedy et al. 2005. Effects of overconsuming Sirco®, a one-a-day fruit juice drink containing 12g/L WSTC, on platelet function in healthy subjects . REC No 05/S0802/77. 4. O’Kennedy et al. 2006c. A pilot study to compare the antiplatelet effects of WSTC in healthy subjects, after consumption in two different food matrices . REC No 06/S0802/60. 5. O’Kennedy et al. 2007. A randomised, controlled and double-blinded crossover study to compare the antiplatelet effects of three different formats of WSTC in healthy humans . REC No 07/S0801/13. 6. Song, V., Sheddon, A., Horgan, G. and O’Kennedy, N. Anticoagulatory and anti-inflammatory activities of WSTC in platelets and endothelial cells. Manuscript for submission ; 2008. 7. Zhang, F., Song, V., Neascu, M., Crosbie, L., Duncan, G., Horgan, G., de Roos, B. and O’Kennedy, N. Flow cytometric and proteomic studies examining the effects of WSTC on platelet function in vitro . Unpublished, 2007/2008. Q-2009-00229

Other acts of the same type
2013/335/EU: Council Decision of 25 June 2013 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Protocol 31 to the EEA Agreement, on cooperation in specific fields outside the four freedoms2013/336/EU: Council Decision of 25 June 2013 increasing the number of Advocates-General of the Court of Justice of the European UnionCouncil Decision 2013/306/CFSP of 24 June 2013 extending the mandate of the European Union Special Representative for Central AsiaCouncil Decision 2013/307/CFSP of 24 June 2013 amending and extending the mandate of the European Union Special Representative for the Southern Mediterranean region2013/313/EU: Council Implementing Decision of 21 June 2013 amending Implementing Decision 2011/77/EU on granting Union financial assistance to Ireland2013/314/EU: Council Decision of 21 June 2013 abrogating Decision 2010/286/EU on the existence of an excessive deficit in Italy2013/315/EU: Council Decision of 21 June 2013 abrogating Decision 2004/918/EC on the existence of an excessive deficit in Hungary2013/316/EU: Council Decision of 21 June 2013 abrogating Decision 2009/588/EC on the existence of an excessive deficit in Lithuania2013/317/EU: Council Decision of 21 June 2013 abrogating Decision 2009/591/EC on the existence of an excessive deficit in Latvia2013/318/EU: Council Decision of 21 June 2013 abrogating Decision 2009/590/EC on the existence of an excessive deficit in Romania2013/323/EU: Council Implementing Decision of 21 June 2013 amending Implementing Decision 2011/344/EU on granting Union financial assistance to Portugal2013/324/EU: Council Decision of 21 June 2013 amending Decision 98/481/EC approving the external auditors of the European Central Bank

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next